- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Podcast: This Week in Managed Care—Right-to-Try Bill Defeated and Other Health News
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week, the top managed care stories included Sanofi offering a deal to payers for its cholesterol drug; a “right-to-try” bill is defeated in the House; and a forum of oncology pharmacists discusses “health insurance” versus “healthcare.”
Listen above or through one of these podcast services:
iTunes: http://apple.co/2eYWTss
TuneIn: http://bit.ly/2gv7iwj
Stitcher: http://bit.ly/2gCqtFg
Read more about the stories in this podcast:
With ODYSSEY Results in Hand, Talks With Payers Begin to Jump Start Praluent Sales
"Right-to-Try" Legislation Defeated in House Amid Doubts About Its Necessity
Coverage of the American College of Cardiology’s 67th Annual Scientific Session & Expo
Rep. Doug Collins: Providing Healthcare vs Health Insurance
National Community Oncology Dispensing Association 2018 Spring Forum
Pembrolizumab Granted Priority Review for Treatment of Cervical Cancer
Association of Community Cancer Centers' 44th annual meeting
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
